Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: an Endocrine Society Clinical Practice Guideline"

Panagiotis Anagnostis^{1

2

3}, Eustathios Kenanidis^{2

3}, Michael Potoupnis^{2

3}, Eleftherios Tsiridis^{2

3}, Dimitrios G Goulis^{1

2}

Affiliations

¹ Unit of Reproductive Endocrinology, 1st Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Greece.
² Centre of Orthopedic and Regenerative Medicine Research (CORE), Center for Interdisciplinary Research and Innovation (CIRI), Aristotle University of Thessaloniki, Thessaloniki, Greece.
³ Academic Orthopedic Department, Papageorgiou General Hospital, Aristotle University Medical School, Thessaloniki, Greece.

Comment

Panagiotis Anagnostis et al. J Clin Endocrinol Metab. 2020.

. 2020 Jan 1;105(1):dgz131.

doi: 10.1210/clinem/dgz131.

Panagiotis Anagnostis^{1

2

3}, Eustathios Kenanidis^{2

3}, Michael Potoupnis^{2

3}, Eleftherios Tsiridis^{2

3}, Dimitrios G Goulis^{1

2}

¹ Unit of Reproductive Endocrinology, 1st Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Greece.
² Centre of Orthopedic and Regenerative Medicine Research (CORE), Center for Interdisciplinary Research and Innovation (CIRI), Aristotle University of Thessaloniki, Thessaloniki, Greece.
³ Academic Orthopedic Department, Papageorgiou General Hospital, Aristotle University Medical School, Thessaloniki, Greece.

No abstract available

Comment on

Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline.
Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D. Eastell R, et al. J Clin Endocrinol Metab. 2019 May 1;104(5):1595-1622. doi: 10.1210/jc.2019-00221. J Clin Endocrinol Metab. 2019. PMID: 30907953